CAS: 93594-39-9; 1-Cyclopropyl-6-Fluoro-7-(4-Formylpiperazin-1-yl)-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid

该化合物是一个合成有机化合物,其结构复杂,包括一个quinline核,一个环丙基和一个管子线藻.该化合物通常具有与七环化合物有关的特性,例如潜在的生物活动,使其对医药化学感兴趣.氟的出现可能会增加其脂性并影响其药用动力特性. 箱酸功能组有助于其极溶剂的酸性和溶性.此外,管状体环上的基可参与各种化学反应,有可能进一步衍生.

结构式图片

相似化合物

105404-65-7 93594-20-8 103237-52-1

上下游产品

formic acid ciprofloxacin hydr°Chloride ciprofloxacin N,N-dimethyl-formamide1-cyclopropyl-6-fluoro-7-(4-(3-(6-fluorobenzo[d]thiazol-2-yl)-4-oxothiazolidin-2-yl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 25H21F2N5O3SC25H21F2N5O3S 26H21FN6O3SC26H21FN6O3S 28H23FN6O4S2C28H23FN6O4S2

合成工艺路线路线简述

    📜1-Cyclopropyl-6-Fluoro-4-Oxo-7-(4-((2-(4-Fluorobenzoyl)Hydrazono)Methyl)Piperazin-1-yl)-1,4-Dihydroquinoline-3-Carboxylic Acid置于水,乙酸酐体系中,用 二甲基亚砜 作为反应溶剂,化学反应 50.83H,反应生成 (环丙沙星m4)
    参考文献:New Fluorine-Containing Hydrazones Active Against Mdr-Tuberculosis
    标题:New Fluorine-Containing Hydrazones Active Against Mdr-Tuberculosis
    摘要:Several New Fluorine-Containing Hydrazones Were Synthesized And Screened For Their In Vitro Anti-Mycobacterial Activity. Nine Of These Derivatives Have Shown A Remarkable Activity Against Mdr-Tb Strain With Mic 0.5 Mu G/ml And High Value Of Selectivity Index (Si). Compound 3H With The Highest Si (1268.58) Was Used For Stability Evaluation With Putative Metabolites (Ciprofloxacin And Formylciprofloxacin) Detection. Compound 3H Was Stable At Ph 7.4 Of Aqueous Buffer And Rat Plasma,In Acidic Buffers (At Ph 3 And 5) Slow Decomposition Was Observed. Interestingly,No Formylciprofloxacin Was Detected In The Solution,And Only Slightly Increased Concentration Of Ciprofloxacin Was Observed Instead. Trifluoromethyl Hydrazones 3F And 3G Exhibited The Best Activity Also Against Two Strains Of Mycobacterium Kansasii (Mic 1-4 Mu Mol/l). All Evaluated Compounds Were Found To Be Non-Cytotoxic. (C) 2011 Elsevier Masson Sas. All Rights Reserved.
    DOI:10.1016/j.Ejmech.2011.07.052

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:S113 | SWISSPHARMA24 | 2024 Swiss Pharmaceutical List with Metabolites | DOI:10.5281/zenodo.10501043
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知